| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/07/1996 | EP0724602A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 08/07/1996 | EP0724599A1 Platelet-derived growth factor analogues |
| 08/07/1996 | EP0724594A1 Regulation of transcription factor, nf-il6/lap |
| 08/07/1996 | EP0724593A1 Coiled-coil stem loop templates |
| 08/07/1996 | EP0724588A1 Drug binding protein |
| 08/07/1996 | EP0724456A1 Antibodies to cd40 |
| 08/07/1996 | EP0724455A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 08/07/1996 | EP0724453A1 The cloning of duffy blood group antigen |
| 08/07/1996 | EP0724436A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 08/07/1996 | EP0724433A1 Method for preparing microspheres comprising a fluidized bed drying step |
| 08/07/1996 | EP0724432A1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 08/07/1996 | EP0724431A1 Methods and compositions for microencapsulation of adjuvants |
| 08/07/1996 | EP0527813B1 T-CEL LYMPHOMA cDNA CLONES |
| 08/07/1996 | CN1128538A Tandem synthetic HIV-1 peptides |
| 08/06/1996 | US5543503 Antiinflammatory agents |
| 08/06/1996 | US5543323 Malaria vaccine |
| 08/06/1996 | US5543320 Genetic engineering |
| 08/06/1996 | US5543312 Gene expression, cloning a dna sequence |
| 08/06/1996 | US5543304 Expressing the protein fused to a nontoxic protein from recombinant dna; isolating using chromatography to bind nontoxic protein; separation |
| 08/06/1996 | US5543145 Pharmaceutical composition and method for the suppression of factor VIII inhibitor production |
| 08/06/1996 | US5543144 Treating hypersensitivities with anti-IGE monoclonal antibodies which bind to IGE-expressing B cells but not basophils |
| 08/01/1996 | WO1996023067A1 Human interleukin-1 receptor accessory protein |
| 08/01/1996 | WO1996023060A1 Method for isolating dendritic cells |
| 08/01/1996 | WO1996022790A1 Composition to ameliorate osteolysis and metastasis |
| 08/01/1996 | WO1996022788A1 LYMPHOTOXIN-α/β COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS |
| 08/01/1996 | WO1996022785A1 Methods for the treatment of acid aspiration-induced acute lung injury |
| 08/01/1996 | WO1996022693A1 Self-renewing pluripotent hematopoietic stem cell compositions, methods of use, and culture systems therefor |
| 08/01/1996 | WO1996015231A3 Method for producing biologicals in protein-free culture |
| 08/01/1996 | WO1996013593A3 Soluble single chain t cell receptors |
| 08/01/1996 | WO1996013592A3 Protein kinase npk-110 |
| 08/01/1996 | CA2211443A1 Lymphotoxin-.alpha./.beta. complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 08/01/1996 | CA2211115A1 Methods for the treatment of acid aspiration-induced acute lung injury |
| 08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
| 07/31/1996 | EP0724016A1 Toxoplasma gondii mimotope polypeptides and uses thereof |
| 07/31/1996 | EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP |
| 07/31/1996 | EP0723664A1 Detection and treatment of breast and gynecological cancer |
| 07/31/1996 | EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 07/31/1996 | EP0723584A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/31/1996 | EP0723556A1 Fas antagonists and uses thereof |
| 07/31/1996 | EP0723458A1 Immune modulation with class ii alpha-chain fragments |
| 07/31/1996 | EP0723440A1 Therapeutic delivery compositions and methods of use thereof |
| 07/31/1996 | EP0723402A1 Senescent cell-derived inhibitors of dna synthesis |
| 07/31/1996 | EP0550665B1 Novel neurothrophic factor |
| 07/31/1996 | EP0469060B1 Autoantibodies which enhance the rate of a chemical reaction |
| 07/31/1996 | EP0446313B1 Fusion proteins comprising TraTp and at least one LHRH analogue |
| 07/31/1996 | CN1128043A Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 07/31/1996 | CA2168381A1 Toxoplasma gondii mimotypic polypeptides and use thereof |
| 07/30/1996 | US5541297 Hypoimmunogenic immunoconjugate of antibody fragment which binds to antigen associated with tumor or protozoa conjugated to drug or modified toxin and to polysaccharide or polyether through thiol-binding linker |
| 07/30/1996 | US5541292 Malaria vaccine |
| 07/30/1996 | US5541291 Polypeptides |
| 07/30/1996 | US5541104 Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 |
| 07/30/1996 | US5541100 Hiv, influenza |
| 07/30/1996 | US5541078 Antigenic peptide sequence of echinococcus granulosus and diagnostic applications |
| 07/30/1996 | US5541077 Fungal stress proteins |
| 07/30/1996 | US5541075 Carbohydrate-based vaccine and diagnostic reagent for trichinosis |
| 07/30/1996 | US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody |
| 07/30/1996 | US5541065 Amplifying nucleic acid sequence from exon two of human leukocyte antigen dpbeta gene in sample, mixing with panel of sequence specific oligonucleotide probes, detecting hybrids formed, determining genotype |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540919 Method for enhancement of production of lymphokines and applications thereof |
| 07/30/1996 | CA1338501C Method of detecting antibody against htlv-iii |
| 07/25/1996 | WO1996022384A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 07/25/1996 | WO1996022377A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | WO1996022373A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | WO1996022368A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | WO1996022360A1 Human prostatic specific reductase |
| 07/25/1996 | WO1996022067A2 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics |
| 07/25/1996 | WO1996022024A1 Receptor specific transepithelial transport of immunogens |
| 07/25/1996 | WO1996009805A3 Chitosan induced immunopotentiation |
| 07/25/1996 | WO1996006177A3 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 07/25/1996 | CA2210997A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | CA2210618A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
| 07/24/1996 | EP0722499A1 Immunoreactive antigens of hepatitis e virus |
| 07/24/1996 | EP0722463A1 Methods and composition for the modulation of host immune response to allergens |
| 07/24/1996 | EP0722344A1 Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
| 07/24/1996 | EP0722343A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 07/24/1996 | EP0722341A1 Improvements in and relating to vaccines |
| 07/24/1996 | EP0722340A1 Immunological tolerance-inducing agent |
| 07/24/1996 | EP0722339A1 $i(VIBRIO CHOLERAE) 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) SEROGROUP VACCINE STRAINS AND METHODS OF MAKING SAME |
| 07/24/1996 | EP0722338A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/24/1996 | EP0722337A1 Cd8?+ cell antiviral factor |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722317A1 Liposomes containing particulate materials |
| 07/24/1996 | EP0612250B1 Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 07/24/1996 | EP0560968B1 Vaccine for neisseria meningitidis infections |
| 07/24/1996 | CN1127139A Preparation of heterogenic animal high immune serum against duck pest and viral hepatitis |
| 07/24/1996 | CN1032348C Method for prepn. of stable immunogen composition for oral administration |
| 07/23/1996 | US5539084 Separation of a specific binding entity for a mixture |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5538866 Immunoassay; medical diagnosis |
| 07/23/1996 | US5538865 Antigens for viral hepatitis |
| 07/23/1996 | US5538854 Method for the determination of predisposition to autoimmune disease |
| 07/23/1996 | US5538844 Transport protein gene from the Huntington's disease region |
| 07/23/1996 | US5538733 Poultry |
| 07/23/1996 | US5538729 Oral treatment of helicobacter infection |
| 07/23/1996 | US5538725 Method of inhibiting metastasis by anti-α6-integrin-antibodies |
| 07/18/1996 | WO1996021736A1 Human geranylgeranyl pyrophosphate synthetase |